GETTING MY BLOCK PAIN RECEPTORS WITH PROLEVIATE TO WORK

The activation of CB1 and CB2 inhibits the formation of intracellular cAMP, hence resulting in a tremendous reduction with the excitatory outcome within the neurons [88,89]. Additionally, the activation of CB2 can even further stop the mast cell degranulation and the discharge of professional-inflammatory mediators, generating the reduction in pain